Novo Nordisk
NVO
549 hedge funds and large institutions have $11.7B invested in Novo Nordisk in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 190 increasing their positions, 194 reducing their positions, and 35 closing their positions.
577% more call options, than puts
Call options by funds: $34.8M | Put options by funds: $5.14M
26% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 35
19% more funds holding in top 10
Funds holding in top 10: 32 → 38 (+6)
4% more funds holding
Funds holding: 526 → 549 (+23)
0.05% less ownership
Funds ownership: 8.92% → 8.87% (-0.05%)
2% less repeat investments, than reductions
Existing positions increased: 190 | Existing positions reduced: 194
13% less capital inflows, than outflows
Capital inflows: $475M | Capital outflows: $544M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$77.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$56.2M |
| 3 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$33M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$26.7M |
| 5 |
WBI Investments
Red Bank,
New Jersey
|
+$26.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$178M |
| 2 |
Harding Loevner
Bridgewater,
New Jersey
|
-$59.1M |
| 3 |
Lazard Asset Management
New York
|
-$21.6M |
| 4 |
Scout Investments
Kansas City,
Missouri
|
-$21.5M |
| 5 |
Bank of New York Mellon
New York
|
-$19.9M |
NVO Hedge Fund Activity: Q4 2015 in Review
549 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2015, worth a combined $11.7B — up 6.5% from $11B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new NVO positions and 35 closed out — a net gain of 9 holders — while 190 added to existing stakes and 194 trimmed.
The largest buyer was WCM Investment Management, adding an estimated $77.3M. The largest seller was Jennison Associates, cutting an estimated $178M.
- 549 institutional investors held Novo Nordisk (NVO) as of Q4 2015, up from 526 in Q3 2015.
- Funds reported $11.7B of Novo Nordisk stock for Q4 2015, up 6.5% quarter-over-quarter.
- 44 funds opened new Novo Nordisk positions in Q4 2015 and 35 closed out, a net change of +9 holders.
- The largest Novo Nordisk buyer in Q4 2015 was WCM Investment Management, an estimated $77.3M added.
- The largest Novo Nordisk seller in Q4 2015 was Jennison Associates, an estimated $178M sold.
Based on aggregated 13F filings for Q4 2015.